Clinical Trial Update: Efficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate the efficacy of aclidinium bromide in chronic obstructive pulmonary disease (COPD); the study is completed and results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Aclidinium bromide (Aclidinium bromide)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: COMPLETED | Results posted: 2012-09-12